1887

Abstract

NF-E2 related factor 2 (Nrf2) is a transcription factor that plays a key role(s) in cellular defence against oxidative stress. In this study, we showed that the expression of Nrf2 was upregulated in primary human foreskin fibroblasts (HFFs), following human cytomegalovirus (HCMV/HHV-5) infection. The expression of haem oxygenase-1, a downstream target of Nrf2, was also increased by HCMV infection, and this induction was suppressed in HFFs expressing a small hairpin RNA (shRNA) against Nrf2. The HCMV-mediated increase in Nrf2 expression was abolished when UV-irradiated virus was used or when the activity of casein kinase 2 was inhibited. Host cells infected by HCMV had higher survival rates following oxidative stress induced by buthionine sulfoximine compared with uninfected control cells, but this cell-protective effect was abolished by the use of Nrf2 shRNA. Our results suggest that HCMV-mediated activation of Nrf2 might be beneficial to the virus by increasing the host cell’s ability to cope with oxidative stress resulting from viral infection and/or inflammation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.052142-0
2013-07-01
2020-07-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/7/1658.html?itemId=/content/journal/jgv/10.1099/vir.0.052142-0&mimeType=html&fmt=ahah

References

  1. Afonyushkin T., Oskolkova O. V., Binder B. R., Bochkov V. N. 2011; Involvement of CK2 in activation of electrophilic genes in endothelial cells by oxidized phospholipids. J Lipid Res 52:98–103 [CrossRef][PubMed]
    [Google Scholar]
  2. Britt W. 2008; Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 325:417–470 [CrossRef][PubMed]
    [Google Scholar]
  3. Browne E. P., Wing B., Coleman D., Shenk T. 2001; Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol 75:12319–12330 [CrossRef][PubMed]
    [Google Scholar]
  4. Buchkovich N. J., Maguire T. G., Paton A. W., Paton J. C., Alwine J. C. 2009; The endoplasmic reticulum chaperone BiP/GRP78 is important in the structure and function of the human cytomegalovirus assembly compartment. J Virol 83:11421–11428 [CrossRef][PubMed]
    [Google Scholar]
  5. Burdette D., Olivarez M., Waris G. 2010; Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J Gen Virol 91:681–690 [CrossRef][PubMed]
    [Google Scholar]
  6. Calkins M. J., Vargas M. R., Johnson D. A., Johnson J. A. 2010; Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol Sci 115:557–568 [CrossRef][PubMed]
    [Google Scholar]
  7. Carvajal-Yepes M., Himmelsbach K., Schaedler S., Ploen D., Krause J., Ludwig L., Weiss T., Klingel K., Hildt E. 2011; Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. J Biol Chem 286:8941–8951 [CrossRef][PubMed]
    [Google Scholar]
  8. Chan K., Lu R., Chang J. C., Kan Y. W. 1996; NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 93:13943–13948 [CrossRef][PubMed]
    [Google Scholar]
  9. Cope A. V., Sabin C., Burroughs A., Rolles K., Griffiths P. D., Emery V. C. 1997; Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis 176:1484–1490 [CrossRef][PubMed]
    [Google Scholar]
  10. Deayton J. R., Sabin C. A., Johnson M. A., Emery V. C., Wilson P., Griffiths P. D. 2004; Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363:2116–2121 [CrossRef][PubMed]
    [Google Scholar]
  11. Emery V. C., Cope A. V., Bowen E. F., Gor D., Griffiths P. D. 1999; The dynamics of human cytomegalovirus replication in vivo. J Exp Med 190:177–182 [CrossRef][PubMed]
    [Google Scholar]
  12. Emery V. C., Sabin C. A., Cope A. V., Gor D., Hassan-Walker A. F., Griffiths P. D. 2000; Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032–2036 [CrossRef][PubMed]
    [Google Scholar]
  13. Fehr A. R., Yu D. 2011; Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts. J Virol 85:663–674 [CrossRef][PubMed]
    [Google Scholar]
  14. Gharbi S. I., Zvelebil M. J., Shuttleworth S. J., Hancox T., Saghir N., Timms J. F., Waterfield M. D. 2007; Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 404:15–21 [CrossRef][PubMed]
    [Google Scholar]
  15. Huh Y. H., Kim Y. E., Kim E. T., Park J. J., Song M. J., Zhu H., Hayward G. S., Ahn J. H. 2008; Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol 82:10444–10454 [CrossRef][PubMed]
    [Google Scholar]
  16. Jang J., Yoon K., Hwang D. W., Lee D. S., Kim S. 2012; A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain. Gene Ther 19:396–403 [CrossRef][PubMed]
    [Google Scholar]
  17. Johnson R. A., Wang X., Ma X. L., Huong S. M., Huang E. S. 2001; Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol 75:6022–6032 [CrossRef][PubMed]
    [Google Scholar]
  18. Joyce M. A., Walters K. A., Lamb S. E., Yeh M. M., Zhu L. F., Kneteman N., Doyle J. S., Katze M. G., Tyrrell D. L. 2009; HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog 5:e1000291 [CrossRef][PubMed]
    [Google Scholar]
  19. Jung G. S., Kim Y. Y., Kim J. I., Ji G. Y., Jeon J. S., Yoon H. W., Lee G. C., Ahn J. H., Lee K. M., Lee C. H. 2011; Full genome sequencing and analysis of human cytomegalovirus strain JHC isolated from a Korean patient. Virus Res 156:113–120 [CrossRef][PubMed]
    [Google Scholar]
  20. Kesic M. J., Simmons S. O., Bauer R., Jaspers I. 2011; Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med 51:444–453 [CrossRef][PubMed]
    [Google Scholar]
  21. Kim K. M., Song J. D., Chung H. T., Park Y. C. 2012; Protein kinase CK2 mediates peroxynitrite-induced heme oxygenase-1 expression in articular chondrocytes. Int J Mol Med 29:1039–1044[PubMed]
    [Google Scholar]
  22. Liu Z. M., Li L. Q., Peng M. H., Liu T. W., Qin Z., Guo Y., Xiao K. Y., Ye X. P., Mo X. S.& other authors ( 2008; Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett 263:212–222 [CrossRef][PubMed]
    [Google Scholar]
  23. Nakaso K., Yano H., Fukuhara Y., Takeshima T., Wada-Isoe K., Nakashima K. 2003; PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546:181–184 [CrossRef][PubMed]
    [Google Scholar]
  24. Niture S. K., Jaiswal A. K. 2010; Hsp90 interaction with INrf2(Keap1) mediates stress-induced Nrf2 activation. J Biol Chem 285:36865–36875 [CrossRef][PubMed]
    [Google Scholar]
  25. Niture S. K., Jain A. K., Jaiswal A. K. 2009; Antioxidant-induced modification of INrf2 cysteine 151 and PKC-δ-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 122:4452–4464 [CrossRef][PubMed]
    [Google Scholar]
  26. Niture S. K., Kaspar J. W., Shen J., Jaiswal A. K. 2010; Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244:37–42 [CrossRef][PubMed]
    [Google Scholar]
  27. Schaedler S., Krause J., Himmelsbach K., Carvajal-Yepes M., Lieder F., Klingel K., Nassal M., Weiss T. S., Werner S., Hildt E. 2010; Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem 285:41074–41086 [CrossRef][PubMed]
    [Google Scholar]
  28. Söderberg-Nauclér C. 2006; Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J Intern Med 259:219–246 [CrossRef][PubMed]
    [Google Scholar]
  29. Speir E., Shibutani T., Yu Z. X., Ferrans V., Epstein S. E. 1996; Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 79:1143–1152 [CrossRef][PubMed]
    [Google Scholar]
  30. Stanton R. J., McSharry B. P., Rickards C. R., Wang E. C., Tomasec P., Wilkinson G. W. 2007; Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. J Virol 81:7860–7872 [CrossRef][PubMed]
    [Google Scholar]
  31. Steininger C. 2007; Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin Microbiol Infect 13:953–963 [CrossRef][PubMed]
    [Google Scholar]
  32. Streblow D. N., Orloff S. L., Nelson J. A. 2007; Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 19:577–582 [CrossRef][PubMed]
    [Google Scholar]
  33. Sykiotis G. P., Bohmann D. 2010; Stress-activated cap’n’collar transcription factors in aging and human disease. Sci Signal 3:re3 [CrossRef][PubMed]
    [Google Scholar]
  34. Tilton C., Clippinger A. J., Maguire T., Alwine J. C. 2011; Human cytomegalovirus induces multiple means to combat reactive oxygen species. J Virol 85:12585–12593 [CrossRef][PubMed]
    [Google Scholar]
  35. Tsutsui Y. 2009; Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit Anom (Kyoto) 49:47–55 [CrossRef][PubMed]
    [Google Scholar]
  36. Valyi-Nagy T., Dermody T. S. 2005; Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histol Histopathol 20:957–967[PubMed]
    [Google Scholar]
  37. van de Berg P. J., Heutinck K. M., Raabe R., Minnee R. C., Young S. L., van Donselaar-van der Pant K. A., Bemelman F. J., van Lier R. A., ten Berge I. J. 2010; Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis 202:690–699 [CrossRef][PubMed]
    [Google Scholar]
  38. Varani S., Landini M. P. 2011; Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2:6 [CrossRef][PubMed]
    [Google Scholar]
  39. Wang L., Chen Y., Sternberg P., Cai J. 2008; Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci 49:1671–1678 [CrossRef][PubMed]
    [Google Scholar]
  40. Yu S. S., Han E., Hong Y., Lee J. T., Kim S., Kim S. 2003; Construction of a retroviral vector production system with the minimum possibility of a homologous recombination. Gene Ther 10:706–711 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.052142-0
Loading
/content/journal/jgv/10.1099/vir.0.052142-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error